Cargando…
Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach
Individuals exposed to spores of B. anthracis must take a course of antibiotics as postexposure prophylaxis (PEP) to prevent inhalation anthrax. During an anthrax event, public health authorities are responsible for conducting dispensing operations to offer PEP to exposed individuals. Jurisdictions...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340788/ https://www.ncbi.nlm.nih.gov/pubmed/30133374 http://dx.doi.org/10.1089/hs.2018.0025 |
_version_ | 1783388830051598336 |
---|---|
author | Misener, Mark Starr, David T. Scaccia, Allison J. Arya, Vibhuti |
author_facet | Misener, Mark Starr, David T. Scaccia, Allison J. Arya, Vibhuti |
author_sort | Misener, Mark |
collection | PubMed |
description | Individuals exposed to spores of B. anthracis must take a course of antibiotics as postexposure prophylaxis (PEP) to prevent inhalation anthrax. During an anthrax event, public health authorities are responsible for conducting dispensing operations to offer PEP to exposed individuals. Jurisdictions have developed antibiotic PEP screening algorithms to determine which antibiotic is appropriate for each individual. Variability exists with regard to screening questions and dispensing decisions based on responses to those questions. It is likely that individuals with similar profiles will receive different antibiotics based solely on the jurisdiction in which they receive their PEP. This lack of consistency among jurisdictions may lead to a loss of confidence in the public health response among the public, the healthcare community, the media, and government leaders, which could compromise the response itself. We present New York City's planning assumptions, screening algorithm, a rationale for our screening questions, and our reasons for excluding screening questions asked by other jurisdictions. We hope that our efforts may assist others in developing and refining their algorithms and associated public messaging and encourage standardization with neighboring jurisdictions where appropriate. |
format | Online Article Text |
id | pubmed-6340788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Mary Ann Liebert, Inc., publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-63407882019-01-22 Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach Misener, Mark Starr, David T. Scaccia, Allison J. Arya, Vibhuti Health Secur Original Articles Individuals exposed to spores of B. anthracis must take a course of antibiotics as postexposure prophylaxis (PEP) to prevent inhalation anthrax. During an anthrax event, public health authorities are responsible for conducting dispensing operations to offer PEP to exposed individuals. Jurisdictions have developed antibiotic PEP screening algorithms to determine which antibiotic is appropriate for each individual. Variability exists with regard to screening questions and dispensing decisions based on responses to those questions. It is likely that individuals with similar profiles will receive different antibiotics based solely on the jurisdiction in which they receive their PEP. This lack of consistency among jurisdictions may lead to a loss of confidence in the public health response among the public, the healthcare community, the media, and government leaders, which could compromise the response itself. We present New York City's planning assumptions, screening algorithm, a rationale for our screening questions, and our reasons for excluding screening questions asked by other jurisdictions. We hope that our efforts may assist others in developing and refining their algorithms and associated public messaging and encourage standardization with neighboring jurisdictions where appropriate. Mary Ann Liebert, Inc., publishers 2018-08-01 2018-12-29 /pmc/articles/PMC6340788/ /pubmed/30133374 http://dx.doi.org/10.1089/hs.2018.0025 Text en © Mark Misener, et al., 2018; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Original Articles Misener, Mark Starr, David T. Scaccia, Allison J. Arya, Vibhuti Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach |
title | Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach |
title_full | Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach |
title_fullStr | Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach |
title_full_unstemmed | Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach |
title_short | Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach |
title_sort | screening for anthrax postexposure antibiotic prophylaxis—the new york city approach |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340788/ https://www.ncbi.nlm.nih.gov/pubmed/30133374 http://dx.doi.org/10.1089/hs.2018.0025 |
work_keys_str_mv | AT misenermark screeningforanthraxpostexposureantibioticprophylaxisthenewyorkcityapproach AT starrdavidt screeningforanthraxpostexposureantibioticprophylaxisthenewyorkcityapproach AT scacciaallisonj screeningforanthraxpostexposureantibioticprophylaxisthenewyorkcityapproach AT aryavibhuti screeningforanthraxpostexposureantibioticprophylaxisthenewyorkcityapproach |